Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.
about
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for managementAllograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profilingDiagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation SocietiesNew-onset diabetes mellitus after kidney transplantation: Current status and future directionsManagement of the hospitalized transplant patientAssociation of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients.A genome-wide association study of recipient genotype and medium-term kidney allograft function.Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification ApproachYin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling.Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on OutcomesAblation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphologyConversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantationPathways to quality inpatient management of hyperglycemia and diabetes: a call to action.Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation.Genetics of new-onset diabetes after transplantation.Prevention and management of transplant-associated diabetes.Complications associated with new-onset diabetes after kidney transplantation.New-onset diabetes after kidney transplantation-changes and challenges.Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.Pretransplant identification of acute rejection risk following kidney transplantation.Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: a systematic review and meta-analysis.The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival.Treating posttransplantation diabetes mellitus.Emerging treatments for post-transplantation diabetes mellitus.Comparison of patient outcome according to renal replacement modality after renal allograft failure.Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the Transplantation and Diabetes (Transdiab) study.How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis.Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient.A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity.Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study.Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study.Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
P2860
Q26795773-92BAFBE1-6C6F-46D0-90E6-A89D04AF0815Q26996813-B67633E9-26BD-48B2-98BD-D8AEE858F7D7Q27024676-8141FBB0-91A5-4351-8A1F-30CF1F34EC01Q28083882-B72CB1D8-72E9-433A-A4F0-389B1240789AQ28084807-0EA97315-D933-4BB2-9347-93E099E768A8Q30423628-5B26CED8-88DF-4A0F-A942-CED1332D66FDQ34329216-4EE5F10E-049D-4B45-BE8C-359E610A75FBQ35124252-25F4C317-9246-42E4-A77B-07262F13AF24Q35219625-E16C541A-0DA4-43A4-B870-5E0C95AD11D8Q35221336-24A2B465-953B-41CA-A269-3AA4B59CFB85Q35785182-0DCFEDD1-BFD3-4041-8BCA-666E6AC37FC0Q35884554-D89BE211-418D-413E-8285-6B6AA530696CQ36541052-0E9C89E6-EE63-49C0-8FF3-C738D915B5D9Q36772577-28890420-B36C-4A74-9BEC-D85C4E12B32DQ36899502-EE94276C-5FA3-458E-9CB5-1908EA30C743Q36942158-F524237A-06C7-4F3D-93A5-18CBAE4C0A77Q36942161-F2565544-20D7-4388-971F-50AAD78B0422Q37097834-3120716D-F145-4B39-934F-1BBB8E764D09Q37733563-091C50D2-3165-4EE2-9200-63421C872F0DQ37952000-2CBBFDDF-AD43-46AB-85BB-CA6D0B2D0AECQ37956123-12018B09-16E6-4880-BE71-175D4062F105Q37962217-E48F786A-0B7A-454B-BCCF-5366031FB994Q38059865-96A88242-DE69-46CB-BCE4-B9C9E179F3C4Q38151922-467DE45F-2582-4510-893D-74A5BBE65EE3Q38242068-A1C2ED03-541E-4184-8145-7493B4DD237CQ38265561-3769286B-C92F-4D74-AE4D-AF97B69A9F3CQ38429887-988637EC-D33A-4AFD-B317-1A01914B03ADQ38441421-B601A290-50B4-4947-8BA4-52A90F065FFEQ38445269-248D69F7-812F-4602-950C-F4B75F6BC085Q38476218-AA0167C4-4666-4F59-A0F7-A0DE1CD43CAAQ38609525-0B718BC3-3E06-4619-A1D2-F4337933019FQ38797551-A07F571D-CBC9-41EA-8201-3EBE3678C9A6Q38941637-EC4D67AB-8623-4671-9673-231E0B449485Q39246422-322C38D1-50E1-43BE-815B-6076F26A1D4CQ39441009-AE2B8351-58E4-4B67-A9DF-E7D1D112DC69Q39474969-5C293521-0398-4DF8-BB5E-710FAE4D0A11Q40245332-A1D03AD5-08BA-4897-ABD9-4217CB019B8BQ40297367-B7137C12-F1F8-41AE-9E0C-03228B00B19AQ40708552-04E1C780-7DEB-4B51-9936-F2A4CAFCD46CQ41001229-16D111B3-E4B2-4290-8256-0B79535FE322
P2860
Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of acute rejection and ...... nt graft and patient survival.
@ast
Impact of acute rejection and ...... nt graft and patient survival.
@en
type
label
Impact of acute rejection and ...... nt graft and patient survival.
@ast
Impact of acute rejection and ...... nt graft and patient survival.
@en
prefLabel
Impact of acute rejection and ...... nt graft and patient survival.
@ast
Impact of acute rejection and ...... nt graft and patient survival.
@en
P2093
P2860
P356
P1476
Impact of acute rejection and ...... nt graft and patient survival.
@en
P2093
Caren L Rose
Edward H Cole
John S Gill
Olwyn Johnston
P2860
P304
P356
10.2215/CJN.04681107
P577
2008-03-05T00:00:00Z